Literature DB >> 8122881

Neuronal migration disorders: positron emission tomography correlations.

N Lee1, R A Radtke, L Gray, P C Burger, T J Montine, G R DeLong, D V Lewis, W J Oakes, A H Friedman, J M Hoffman.   

Abstract

We analyzed the interictal [18F]fluoro-2-deoxy-D-glucose positron emission tomography (PET) findings of 17 epileptic patients with neuronal migration disorders (NMDs). Fifteen patients had abnormal PET findings, i.e., focal hypometabolism in 9 patients and displaced metabolic activity of normal gray matter in 6. All 15 patients had magnetic resonance imaging (MRI) abnormalities; however, PET abnormality assisted in the identification of NMDs on MRI in 3 patients. Two patients with negative MRI also had negative PET studies. PET hypometabolism appeared to correlate with severity of neuronal dysgenesis or temporal lobe involvement, or both. Displaced metabolic activity of gray matter is regarded as a unique interictal [18F]fluoro-2-deoxy-D-glucose-PET finding in NMD. This study demonstrates variable metabolic patterns in NMD and that PET may be a useful complement to MRI in the evaluation of NMD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8122881     DOI: 10.1002/ana.410350308

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

1.  Proton MR spectroscopy of polymicrogyria and heterotopia.

Authors:  Elysa Widjaja; Paul D Griffiths; Iain D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

2.  'Double cortex' sign on FDG-PET/CT in diffuse band heterotopia.

Authors:  Madhavi Tripathi; Manjari Tripathi; Ganesh Kumar; Arun Malhotra; Chandra Sekhar Bal
Journal:  Indian J Nucl Med       Date:  2013-10

3.  Multimodality Image Post-processing in Detection of Extratemporal MRI-Negative Cortical Dysplasia.

Authors:  Wen-Han Hu; Xiu Wang; Li-Na Liu; Xiao-Qiu Shao; Kai Zhang; Yan-Shan Ma; Lin Ai; Jun-Ju Li; Jian-Guo Zhang
Journal:  Front Neurol       Date:  2018-06-14       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.